OKYO Pharma Announces Chairman and Founder Acquires Shares

Summary by AI BETAClose X

OKYO Pharma announced that Gabriele Cerrone, Executive Chairman, through Panetta Partners Limited, acquired 10,119 ordinary shares on NASDAQ at $1.59 per share, increasing his total beneficial holding to 10,526,416 shares. This purchase by a key executive may signal confidence in the company's development of urcosimod, a therapeutic candidate for neuropathic corneal pain and inflammatory eye diseases, following positive Phase 2a data and ahead of a planned ~150 subject Phase 2b/3 study.

Disclaimer*

UK 100

Latest directors dealings